Revelation Biosciences Statistics
Total Valuation
REVB has a market cap or net worth of $2.92 million. The enterprise value is -$11.63 million.
Market Cap | 2.92M |
Enterprise Value | -11.63M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
Earnings Date | Aug 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
REVB has 1.63 million shares outstanding. The number of shares has increased by 555.96% in one year.
Shares Outstanding | 1.63M |
Shares Change (YoY) | +555.96% |
Shares Change (QoQ) | +376.66% |
Owned by Insiders (%) | 0.32% |
Owned by Institutions (%) | 0.52% |
Float | 1.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 7.79 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.31 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with zero debt.
Current Ratio | 2.80 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -98.60% and return on invested capital (ROIC) is -94.36%.
Return on Equity (ROE) | -98.60% |
Return on Assets (ROA) | -62.70% |
Return on Capital (ROIC) | -94.36% |
Revenue Per Employee | n/a |
Profits Per Employee | -$995,654 |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.65% in the last 52 weeks. The beta is 0.19, so REVB's price volatility has been lower than the market average.
Beta (5Y) | 0.19 |
52-Week Price Change | -93.65% |
50-Day Moving Average | 2.08 |
200-Day Moving Average | 9.61 |
Relative Strength Index (RSI) | 39.28 |
Average Volume (20 Days) | 1,850,877 |
Short Selling Information
The latest short interest is 36,972, so 2.26% of the outstanding shares have been sold short.
Short Interest | 36,972 |
Short Previous Month | 22,017 |
Short % of Shares Out | 2.26% |
Short % of Float | 2.28% |
Short Ratio (days to cover) | 0.82 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.94M |
Pretax Income | -8.96M |
Net Income | -8.96M |
EBITDA | -8.94M |
EBIT | -8.96M |
Earnings Per Share (EPS) | -$35.39 |
Balance Sheet
The company has $14.55 million in cash and no debt, giving a net cash position of $14.55 million or $8.91 per share.
Cash & Cash Equivalents | 14.55M |
Total Debt | n/a |
Net Cash | 14.55M |
Net Cash Per Share | $8.91 |
Equity (Book Value) | 9.47M |
Book Value Per Share | 5.80 |
Working Capital | 9.40M |
Cash Flow
In the last 12 months, operating cash flow was -$8.55 million and capital expenditures -$19,172, giving a free cash flow of -$8.57 million.
Operating Cash Flow | -8.55M |
Capital Expenditures | -19,172 |
Free Cash Flow | -8.57M |
FCF Per Share | -$7.86 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
REVB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -555.96% |
Shareholder Yield | -555.96% |
Earnings Yield | -306.57% |
FCF Yield | -293.14% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:30.
Last Split Date | Jan 25, 2024 |
Split Type | Reverse |
Split Ratio | 1:30 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |